Use of copy number variation polymorphism to assess cellular and cell-free DNA chimerism following transplantation
Year: 2019
Type: dissertation
Abstract: A state of genetic chimerism is created by allogenic transplantation, the quality and quantity of which may have diagnostic significance.The monitoring of cellular macrochimerism following allogeneic hematopoietic cell transplantation (HCT) is standard of care.It provides an assessment of engraftment, prognostic information, and guides therapeutic interventions.Separately, the discovery of cell-free DNA (cfDNA) chimerism following solid organ transplantation has raised the possibility that increases in donor genotype graft-derived cfDNA may be biomarker for rejection.As a result of these and other developments, the clinical and research requirements for chimerism analysis in the transplantation context exceeds the capabilities offered by existing methodologies.To address this, a panel of 39 droplet digital PCR (ddPCR) assays was developed.These targeted highly polymorphic copy number variation (CNV) loci strategically selected using a population genomics approach to maximise the probability of a donor one copy, recipient zero copy genotype combination (and vice versa).These informative combinations create a negative background against which absolute quantification of the one copy genotype can be performed using ddPCR.Analytical validation of the developed chimerism analysis method for absolute quantification of cfDNA was performed.All studied assays performed linearly across the range <6-1280 copies/mL.Limit of blank was 0 copies/mL, limit of detection was 6 copies/mL, and limit of quantification was 8 copies/mL.A method for genotyping donor and recipient informative CNV loci from chimeric cfDNA was developed and conceptually validated using donor and recipient genomic DNA.The developed chimerism analysis method was used to evaluate the diagnostic validity of absolute measurements of plasma graft-derived cfDNA and total cfDNA, as well as the relative measure of graft fraction, for the diagnosis of rejection.61 indication biopsy-matched samples were studied.For the diagnosis of antibody mediated rejection, the receiver-operator characteristic area under the curves of graft-derived cfDNA and graft fraction were 0.91 (95% CI 0.82-0.98)and 0.89 (95% CI 0.79-0.98),respectively.Both measures did not diagnose borderline or type 1A cellular mediated rejection.Analytical validation was also performed for the quantification of cellular chimerism in blood following allogeneic HCT.CNV chimerism results were compared against established fluorescence in situ hybridization, single nucleotide polymorphism, and short tandem repeatbased methods with excellent correlation.Using 30 ng of DNA, the limit of detection was 0.05% chimerism and the limit of quantification was 0.5% chimerism.Linear performance was established between <0.05%-100% chimerism.High informativity was seen with a median of iii four informative markers detectable per individual in 39 recipients and 43 donor genomes studied.The strength of this approach was exemplified in a multi-donor case involving four genomes, three of which were related.In conclusion, this thesis describes the development and analytical validation of a novel, highly informative test for cellular and cfDNA chimerism analysis based upon highly polymorphic CNV and absolute quantification via ddPCR.In addition to its use in the diagnosis of KT rejection and detection of chimerism after allogeneic HCT, the method holds promise as a means to study chimerism more broadly and in a variety of compartments.
Author: John Whitlam
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: copy number variation, chimerism, cell-free DNA, macrochimerism, hematopoietic stem cell transplantation, solid organ transplantation, antibody-mediated rejection, droplet digital PCR, absolute quantification, transplant rejection diagnosis, fluorescence in situ hybridization comparison, single nucleotide polymorphisms
Open Access status: green
Funders: Children’s Hospital of Wisconsin Research Institute, Murdoch Children's Research Institute, Australian Government, Kidney Health Australia, Roche Organ Transplant Research Foundation, University of Melbourne, State Government of Victoria, Medical Research Council, National Health and Medical Research Council
OpenAlex ID: W3005054000
